Przejdź do zawartości
Merck

The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy.

Immunity (2012-07-04)
Yu Lei, Haitao Wen, Yanbao Yu, Debra J Taxman, Lu Zhang, Douglas G Widman, Karen V Swanson, Kwun-Wah Wen, Blossom Damania, Chris B Moore, Patrick M Giguère, David P Siderovski, John Hiscott, Babak Razani, Clay F Semenkovich, Xian Chen, Jenny P-Y Ting
ABSTRAKT

The mitochondrial protein MAVS (also known as IPS-1, VISA, and CARDIF) interacts with RIG-I-like receptors (RLRs) to induce type I interferon (IFN-I). NLRX1 is a mitochondrial nucleotide-binding, leucine-rich repeats (NLR)-containing protein that attenuates MAVS-RLR signaling. Using Nlrx1(-/-) cells, we confirmed that NLRX1 attenuated IFN-I production, but additionally promoted autophagy during viral infection. This dual function of NLRX1 paralleled the previously described functions of the autophagy-related proteins Atg5-Atg12, but NLRX1 did not associate with Atg5-Atg12. High-throughput quantitative mass spectrometry and endogenous protein-protein interaction revealed an NLRX1-interacting partner, mitochondrial Tu translation elongation factor (TUFM). TUFM interacted with Atg5-Atg12 and Atg16L1 and has similar functions as NLRX1 by inhibiting RLR-induced IFN-I but promoting autophagy. In the absence of NLRX1, increased IFN-I and decreased autophagy provide an advantage for host defense against vesicular stomatitis virus. This study establishes a link between an NLR protein and the viral-induced autophagic machinery via an intermediary partner, TUFM.